BTC Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
BTC Capital Management's LGND Position: Q2 2026 in Review
BTC Capital Management reduced its Ligand Pharmaceuticals (LGND) stake by 1.1% in Q2 2026, selling an estimated $6.13K and leaving 2,364 shares worth $760K. The position accounts for 0.05% of the portfolio, ranked #156.
BTC Capital Management first reported a position in LGND in Q4 2020 and has held it in 19 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- BTC Capital Management held 2,364 shares of Ligand Pharmaceuticals worth $760K as of Q2 2026.
- BTC Capital Management sold 26 Ligand Pharmaceuticals shares in Q2 2026, an estimated $6.13K.
- Ligand Pharmaceuticals made up 0.05% of BTC Capital Management's portfolio in Q2 2026, its #156 holding.
- BTC Capital Management first reported a position in Ligand Pharmaceuticals in Q4 2020 and has held it in 19 quarters since.
- 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.